Clinical trial · Interventional
Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease
Effect and Safety of Xiao'er Jiebiao Oral Liquid in Combination With Standard Treatment on Hand-foot-mouth Disease in Pediatric Patients
NCT02328651CI-TRIAL-00034169completedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a single-blinded randomized trial aiming to evaluate the effectiveness of Xiaoer Jiebiao Oral liquid in combination with Ribavirin treatment on patients with hand-foot-mouth disease compared with the controlgroup that recieve only libavirin treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Handfoot-mouth Disease | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ribavirin | Drug | — | UNRESOLVED |
| Ribavirin plus Xiao'er jiebiao oral liquid | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Ribavirin treatment plus testing drug
- interventionNames
- Drug: Ribavirin plus Xiao'er jiebiao oral liquid
- type
- ACTIVE_COMPARATOR
- label
- Ribavirin treatment
- interventionNames
- Drug: Ribavirin
Primary outcomes (3)
- measure
- Time (hours) taken from treatment start till body temperature dropping to normal
- timeFrame
- time length( hours) from treatment starting to the time that body temperature drop to normal 37.0 degree for 12 hours
- measure
- Time (hours) taken from disease onset till body temperature dropping to normal
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Year
- Maximum age
- 5 Years
Show eligibility criteria text
Inclusion Criteria:subjects should meet all of the following * diagnosed as hand-foot-mouth disease grade I or grade II; * body temperature at admission T\>38℃，fever length\<48 hours; * no need for hormonotherapy or immunoglobulin therapy. * signed written informed consent form Exclusion Criteria:subjects should be excluded if meet any of the following * with history of any heart, lung, kidney or liver diseases; under any hormonotherapy, immunoglobulin therapy or any other therapy.
References
Publications (0)
Data not yet available
No reference posted for this study.